- Home
- BIRK vs ICLR Comparison
BIRK vs ICLR Comparison
Compare BIRK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIRK | ICLR |
|---|---|---|
| Founded | 1774 | 1990 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.1B |
| IPO Year | 2023 | 2001 |
Fundamental Metrics
Financial Performance| Metric | BIRK | ICLR |
|---|---|---|
| Price | $38.67 | $109.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $62.69 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.9M | 754.3K |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.76 | N/A |
| Revenue Next Year | $14.29 | N/A |
| P/E Ratio | $17.48 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.06 | $66.57 |
| 52 Week High | $57.39 | $211.00 |
Technical Indicators
Market Signals| Indicator | BIRK | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 53.21 |
| Support Level | $37.73 | $95.75 |
| Resistance Level | $42.19 | $114.75 |
| Average True Range (ATR) | 1.61 | 5.20 |
| MACD | 0.55 | 1.56 |
| Stochastic Oscillator | 95.74 | 74.22 |
Price Performance
Historical ComparisonAbout BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.